Literature DB >> 21324791

Early-stage ovarian cancer management: still a challenge.

Antonio González Martín.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21324791     DOI： 10.1007/s12094-011-0619-8

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  7 in total

Review 1.  Epithelial ovarian carcinoma: current evidences and future perspectives in the first-line setting.

Authors:  Antonio González-Martín; Gemma Toledo; Luis Chiva
Journal:  Clin Transl Oncol       Date:  2010-06       Impact factor: 3.405

2.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

3.  Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma.

Authors:  I Vergote; J De Brabanter; A Fyles; K Bertelsen; N Einhorn; P Sevelda; M E Gore; J Kaern; H Verrelst; K Sjövall; D Timmerman; J Vandewalle; M Van Gramberen; C G Tropé
Journal:  Lancet       Date:  2001-01-20       Impact factor: 79.321

Review 4.  Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

Authors:  José A García-Sáenz; Ana Custodio; Antonio Casado; José Antonio Vidart; Pluvio J Coronado; Miguel Martín; Sara López-Tarruella; Javier Puente; Cristina Fernández; Eduardo Díaz-Rubio
Journal:  Clin Transl Oncol       Date:  2011-02       Impact factor: 3.405

5.  Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Authors:  Jeffrey Bell; Mark F Brady; Robert C Young; Janice Lage; Joan L Walker; Katherine Y Look; G Scott Rose; Nick M Spirtos
Journal:  Gynecol Oncol       Date:  2006-07-24       Impact factor: 5.482

6.  Ovarian cancer.

Authors:  Bryan T Hennessy; Robert L Coleman; Maurie Markman
Journal:  Lancet       Date:  2009-09-28       Impact factor: 79.321

7.  International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma.

Authors:  J Baptist Trimbos; Mahesh Parmar; Ignace Vergote; David Guthrie; Giorgio Bolis; Nicoletta Colombo; Jan B Vermorken; Valter Torri; Constantino Mangioni; Sergio Pecorelli; Andrea Lissoni; Ann Marie Swart
Journal:  J Natl Cancer Inst       Date:  2003-01-15       Impact factor: 13.506
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.